Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the progress of the plan for shareholders holding 5% or more of the shares to increase their holdings and the plan to increase their holdings more than half of the time

Nov 26, 2024 00:00

Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on extending the 2023 shareholders\' meeting resolution on the plan to issue A shares to specific targets and the validity period of related authorizations

Nov 14, 2024 00:00

Hangzhou Tianmu Mountain Pharmaceutical Co., Ltd.'s indicative announcement on the plan for shareholders holding more than 5% to increase their holdings of the company's shares.

Aug 24, 2024 00:00

Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the company\'s issuance of A-shares to specific targets obtained approval from the Laoshan District Finance Bureau of Qingdao

Dec 7, 2023 00:00

Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the voluntary commitment of 5% or more of majority shareholders not to reduce their holdings of the company

Nov 2, 2023 00:00

Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the progress of the majority shareholders\' agreement to transfer the company\'s shares to complete registration, transfer, and change of control

Oct 14, 2023 00:00

Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the progress of more than 5% of the majority shareholders of the company signed a supplementary agreement to the “Share Transfer Agreement” and a change in control

Sep 28, 2023 00:00

Hangzhou Tianmushan Pharmaceutical\'s announcement on the proposed changes in the company\'s controlling shareholders and actual controllers and the signing of supplementary agreements and control changes to the “Share Transfer Agreement”

Sep 23, 2023 00:00

Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the proposed change in the company\'s controlling shareholder and actual controller and the signing of the “Share Transfer Agreement” and the change of control

Sep 19, 2023 00:00

Hangzhou Tianmushan Pharmaceutical Co., Ltd. Equity Change Report (Yongxinhuarui)

Aug 23, 2023 00:00

Hangzhou Tianmushan Pharmaceutical Co., Ltd. Simplified Equity Change Report (Yuanjia Medical)

Aug 22, 2023 00:00

Verification and analysis report on Hangzhou Tianmushan Pharmaceutical Co., Ltd.\'s 2023 plan to issue A-shares to specific targets

Aug 21, 2023 00:00

Prompt announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the disclosure of the company\'s plan to issue A-shares to specific targets in 2023

Aug 21, 2023 00:00

Written review opinions of the Board of Supervisors of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on matters relating to the company\'s issuance of shares to specific targets

Aug 21, 2023 00:00

Verification and analysis report on Hangzhou Tianmushan Pharmaceutical Co., Ltd.\'s 2023 plan to issue A-shares to specific targets

Aug 21, 2023 00:00

Hangzhou Tianmushan Pharmaceutical Co., Ltd.\'s shareholder dividend return plan for the next three years (2023-2025)

Aug 21, 2023 00:00

Reminder of Hangzhou Tianmushan Pharmaceutical Co., Ltd. regarding proposed changes in the company\'s controlling shareholder and actual controller and signing the “Share Transfer Agreement” and the “Share Subscription Agreement with Conditions Effective”

Aug 21, 2023 00:00

Proposal for Hangzhou Tianmushan Pharmaceutical Co., Ltd.\'s plan to issue A-shares to specific targets in 2023

Aug 21, 2023 00:00

Announcement on diluted immediate returns and filling measures for issuing A-shares to specific targets in 2023 and commitments made by related entities

Aug 21, 2023 00:00

Announcement of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on providing financial support or compensation to investors who issued shares to specific targets and did not participate directly or through stakeholders in the subscription in 2023

Aug 21, 2023 00:00